December 12 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev has acquired 41,836 shares in the company at a weighted average price of 3.4461 levs ($1.96/1.76 euro) per share.